

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.49963769 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.42579453 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.42579453 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.31892414 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.39287410 |
| 6 | negative T cell selection (GO:0043383) | 5.23378831 |
| 7 | negative thymic T cell selection (GO:0045060) | 5.18955956 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.98214464 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.92082751 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.81172313 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.81172313 |
| 12 | T cell migration (GO:0072678) | 4.78064860 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.71951777 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.70908457 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.56267998 |
| 16 | leukocyte aggregation (GO:0070486) | 4.51521206 |
| 17 | * response to type I interferon (GO:0034340) | 4.46735125 |
| 18 | * cellular response to type I interferon (GO:0071357) | 4.43311536 |
| 19 | * type I interferon signaling pathway (GO:0060337) | 4.43311536 |
| 20 | interferon-gamma production (GO:0032609) | 4.27746275 |
| 21 | thymic T cell selection (GO:0045061) | 4.22750600 |
| 22 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.17164114 |
| 23 | cellular response to interleukin-15 (GO:0071350) | 4.11909907 |
| 24 | response to interleukin-15 (GO:0070672) | 4.09697273 |
| 25 | T cell selection (GO:0045058) | 4.08329182 |
| 26 | positive T cell selection (GO:0043368) | 4.05338438 |
| 27 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.02471526 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.96111562 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 3.94869234 |
| 30 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.91062351 |
| 31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.86229269 |
| 32 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.77621152 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.76827467 |
| 34 | regulation of B cell differentiation (GO:0045577) | 3.74352593 |
| 35 | positive regulation of interferon-alpha production (GO:0032727) | 3.73365577 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.67679588 |
| 37 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.67384982 |
| 38 | mast cell activation (GO:0045576) | 3.61380435 |
| 39 | cellular response to zinc ion (GO:0071294) | 3.60630421 |
| 40 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.60485051 |
| 41 | cellular response to interferon-beta (GO:0035458) | 3.59778525 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.59760952 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.59138616 |
| 44 | regulation of interferon-alpha production (GO:0032647) | 3.56382371 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.56341837 |
| 46 | T cell costimulation (GO:0031295) | 3.50489858 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.48319104 |
| 48 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.45433747 |
| 49 | lymphocyte costimulation (GO:0031294) | 3.45354305 |
| 50 | NIK/NF-kappaB signaling (GO:0038061) | 3.44275822 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43597517 |
| 52 | regulation of regulatory T cell differentiation (GO:0045589) | 3.42886244 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.42318021 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41059032 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.40099992 |
| 56 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.39386431 |
| 57 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.39182337 |
| 58 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.35555565 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.32379581 |
| 60 | positive regulation of interleukin-2 production (GO:0032743) | 3.29880960 |
| 61 | detection of molecule of bacterial origin (GO:0032490) | 3.29488874 |
| 62 | defense response to protozoan (GO:0042832) | 3.29326183 |
| 63 | T cell receptor signaling pathway (GO:0050852) | 3.28646487 |
| 64 | leukocyte cell-cell adhesion (GO:0007159) | 3.27895423 |
| 65 | myeloid dendritic cell activation (GO:0001773) | 3.27597896 |
| 66 | positive regulation by symbiont of host defense response (GO:0052509) | 3.25654208 |
| 67 | modulation by symbiont of host defense response (GO:0052031) | 3.25654208 |
| 68 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.25654208 |
| 69 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.25654208 |
| 70 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.25654208 |
| 71 | modulation by symbiont of host immune response (GO:0052553) | 3.25654208 |
| 72 | neutrophil activation (GO:0042119) | 3.22557671 |
| 73 | detection of other organism (GO:0098543) | 3.21599904 |
| 74 | positive regulation of humoral immune response (GO:0002922) | 3.20660288 |
| 75 | regulation of RIG-I signaling pathway (GO:0039535) | 3.20343252 |
| 76 | regulation of response to interferon-gamma (GO:0060330) | 3.20277549 |
| 77 | positive regulation of isotype switching (GO:0045830) | 3.19740622 |
| 78 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.19674777 |
| 79 | response to protozoan (GO:0001562) | 3.16699038 |
| 80 | tolerance induction (GO:0002507) | 3.15202406 |
| 81 | regulation of tolerance induction (GO:0002643) | 3.15114722 |
| 82 | microglial cell activation (GO:0001774) | 3.14273714 |
| 83 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13893900 |
| 84 | positive regulation of defense response to virus by host (GO:0002230) | 3.13526323 |
| 85 | natural killer cell activation (GO:0030101) | 3.12930167 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11847650 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 3.11398331 |
| 88 | response to interferon-beta (GO:0035456) | 3.11253361 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10971519 |
| 90 | cellular response to exogenous dsRNA (GO:0071360) | 3.08730570 |
| 91 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.07934704 |
| 92 | detection of external biotic stimulus (GO:0098581) | 3.06172731 |
| 93 | respiratory burst (GO:0045730) | 3.05488131 |
| 94 | B cell mediated immunity (GO:0019724) | 3.05125095 |
| 95 | detection of bacterium (GO:0016045) | 3.04730206 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04220326 |
| 97 | response to host immune response (GO:0052572) | 3.04220326 |
| 98 | response to peptidoglycan (GO:0032494) | 3.02758625 |
| 99 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.02636671 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.02636671 |
| 101 | response to interferon-alpha (GO:0035455) | 3.02057966 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01722254 |
| 103 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.01525968 |
| 104 | granulocyte activation (GO:0036230) | 3.00501878 |
| 105 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.99712851 |
| 106 | cellular extravasation (GO:0045123) | 2.98294361 |
| 107 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.97896413 |
| 108 | positive regulation of B cell mediated immunity (GO:0002714) | 2.97896413 |
| 109 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.96142005 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.94743180 |
| 111 | activated T cell proliferation (GO:0050798) | 2.92693878 |
| 112 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.92621386 |
| 113 | lymphocyte migration (GO:0072676) | 2.92224275 |
| 114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91552612 |
| 115 | negative regulation of viral genome replication (GO:0045071) | 2.91490778 |
| 116 | positive regulation of tolerance induction (GO:0002645) | 2.91277558 |
| 117 | interferon-gamma secretion (GO:0072643) | 2.90822572 |
| 118 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89525907 |
| 119 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88630950 |
| 120 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88630950 |
| 121 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88501334 |
| 122 | response to host (GO:0075136) | 2.88501334 |
| 123 | response to host defenses (GO:0052200) | 2.88501334 |
| 124 | mature B cell differentiation (GO:0002335) | 2.88032567 |
| 125 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.86597733 |
| 126 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86115055 |
| 127 | positive regulation of interferon-beta production (GO:0032728) | 2.86113586 |
| 128 | positive regulation of DNA recombination (GO:0045911) | 2.85287362 |
| 129 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84539987 |
| 130 | T cell proliferation (GO:0042098) | 2.81867132 |
| 131 | positive regulation of interferon-gamma production (GO:0032729) | 2.81786054 |
| 132 | regulation of germinal center formation (GO:0002634) | 2.81480752 |
| 133 | myeloid cell activation involved in immune response (GO:0002275) | 2.79018756 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.75780717 |
| 135 | negative regulation of adaptive immune response (GO:0002820) | 2.75429363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.58024517 |
| 2 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.15921452 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.20524769 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.10991900 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.08658700 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.76786218 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.63996974 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.47031781 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.46250664 |
| 10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.40488322 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.38288796 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.37476166 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01544492 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95106371 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.87971596 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.85276044 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81688275 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.74138931 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53128894 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.49569140 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.43383403 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33794995 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33344541 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.33287870 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32448889 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.22802092 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22759532 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03846558 |
| 29 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.96574700 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94261232 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93345048 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89043185 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84665811 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80036200 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77168796 |
| 36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75554342 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.73252829 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69529596 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67996903 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67407166 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64034076 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62320126 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62082968 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58742664 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.57227329 |
| 46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.52952155 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49575675 |
| 48 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42950430 |
| 49 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38571811 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37783918 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37653477 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37537914 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36912520 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35987004 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34302007 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32653105 |
| 57 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30394980 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30017862 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.29765380 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29219453 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20264378 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.18335661 |
| 63 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13987578 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12139169 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08725576 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08666876 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08386462 |
| 68 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07605998 |
| 69 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07256056 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06432209 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06201409 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06048797 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05542628 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05427653 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04787326 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04765017 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04513848 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02674856 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00273753 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99965825 |
| 81 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98609565 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96475279 |
| 83 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95420968 |
| 84 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94798542 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94390733 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93968278 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92255526 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92100631 |
| 89 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91770605 |
| 90 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.91109832 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90445685 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89475938 |
| 93 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86348968 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85524603 |
| 95 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82163755 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81861644 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81595732 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79741365 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79113635 |
| 100 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78597498 |
| 101 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77581726 |
| 102 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76386998 |
| 103 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.75915034 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75546621 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.74733726 |
| 106 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73921703 |
| 107 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73509994 |
| 108 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73508127 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.73278556 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72455652 |
| 111 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.71339026 |
| 112 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71002236 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70210790 |
| 114 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69591472 |
| 115 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69487320 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69310270 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67695346 |
| 118 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66516995 |
| 119 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.66456315 |
| 120 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64886292 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64234315 |
| 122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64031409 |
| 123 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.63681609 |
| 124 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.63678376 |
| 125 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63666355 |
| 126 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.61826931 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59750919 |
| 128 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59330724 |
| 129 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.58980255 |
| 130 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.58530834 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.57455174 |
| 132 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.56022711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.87381252 |
| 2 | MP0005671_abnormal_response_to | 3.95544422 |
| 3 | MP0000685_abnormal_immune_system | 3.64200525 |
| 4 | MP0009785_altered_susceptibility_to | 3.57140613 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.52417439 |
| 6 | MP0001790_abnormal_immune_system | 3.47847123 |
| 7 | MP0005387_immune_system_phenotype | 3.47847123 |
| 8 | MP0001800_abnormal_humoral_immune | 3.39663417 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.22035079 |
| 10 | MP0005025_abnormal_response_to | 2.98704163 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.98262802 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.97374717 |
| 13 | MP0002723_abnormal_immune_serum | 2.95583437 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.87247256 |
| 15 | MP0001819_abnormal_immune_cell | 2.86033648 |
| 16 | MP0003724_increased_susceptibility_to | 2.82210953 |
| 17 | MP0003436_decreased_susceptibility_to | 2.82110855 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.65614904 |
| 19 | MP0002419_abnormal_innate_immunity | 2.62119319 |
| 20 | MP0006082_CNS_inflammation | 2.58837473 |
| 21 | MP0002398_abnormal_bone_marrow | 2.54761048 |
| 22 | MP0000716_abnormal_immune_system | 2.35848234 |
| 23 | MP0002006_tumorigenesis | 2.28260421 |
| 24 | MP0003303_peritoneal_inflammation | 2.22529435 |
| 25 | MP0002405_respiratory_system_inflammati | 2.20348262 |
| 26 | MP0002396_abnormal_hematopoietic_system | 2.14488860 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.08373450 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.04194366 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.00391155 |
| 30 | MP0002722_abnormal_immune_system | 1.99623595 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.99409386 |
| 32 | MP0002429_abnormal_blood_cell | 1.92674220 |
| 33 | MP0004947_skin_inflammation | 1.91229243 |
| 34 | MP0001873_stomach_inflammation | 1.88438433 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.88004139 |
| 36 | MP0004510_myositis | 1.85219751 |
| 37 | MP0001853_heart_inflammation | 1.82018403 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.76662346 |
| 39 | MP0005310_abnormal_salivary_gland | 1.54632879 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.52293138 |
| 41 | MP0000858_altered_metastatic_potential | 1.46823277 |
| 42 | MP0008469_abnormal_protein_level | 1.46585361 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.45210376 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.44120846 |
| 45 | MP0002933_joint_inflammation | 1.42512181 |
| 46 | MP0003866_abnormal_defecation | 1.41492552 |
| 47 | MP0003448_altered_tumor_morphology | 1.40420341 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.33202896 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.33202896 |
| 50 | MP0009764_decreased_sensitivity_to | 1.29855795 |
| 51 | MP0004883_abnormal_blood_vessel | 1.28457019 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.23030504 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.22374400 |
| 54 | MP0009278_abnormal_bone_marrow | 1.17858889 |
| 55 | MP0005164_abnormal_response_to | 1.17612075 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.09777800 |
| 57 | MP0008057_abnormal_DNA_replication | 1.07223000 |
| 58 | MP0005058_abnormal_lysosome_morphology | 0.99829914 |
| 59 | MP0001851_eye_inflammation | 0.98378759 |
| 60 | MP0000490_abnormal_crypts_of | 0.97243250 |
| 61 | MP0000343_altered_response_to | 0.95011348 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 0.94085372 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.93501413 |
| 64 | MP0003252_abnormal_bile_duct | 0.90494233 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 0.89988866 |
| 66 | MP0008260_abnormal_autophagy | 0.89428165 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.89079683 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.88462582 |
| 69 | MP0009763_increased_sensitivity_to | 0.86942310 |
| 70 | MP0002132_abnormal_respiratory_system | 0.86688513 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.85041520 |
| 72 | MP0003045_fibrosis | 0.83862404 |
| 73 | MP0003828_pulmonary_edema | 0.80914125 |
| 74 | MP0005451_abnormal_body_composition | 0.80800550 |
| 75 | MP0000569_abnormal_digit_pigmentation | 0.80605139 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.78437939 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.77779954 |
| 78 | MP0002009_preneoplasia | 0.76965880 |
| 79 | MP0004130_abnormal_muscle_cell | 0.76881876 |
| 80 | MP0003195_calcinosis | 0.75633527 |
| 81 | MP0004381_abnormal_hair_follicle | 0.74968208 |
| 82 | MP0000604_amyloidosis | 0.71208390 |
| 83 | MP0003646_muscle_fatigue | 0.70920008 |
| 84 | MP0003950_abnormal_plasma_membrane | 0.70039223 |
| 85 | MP0006054_spinal_hemorrhage | 0.69860189 |
| 86 | MP0000249_abnormal_blood_vessel | 0.67599438 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.64900674 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.63903620 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.62753415 |
| 90 | MP0002168_other_aberrant_phenotype | 0.61652416 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.60831169 |
| 92 | MP0001958_emphysema | 0.60661101 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.60071725 |
| 94 | MP0010307_abnormal_tumor_latency | 0.59522731 |
| 95 | MP0005166_decreased_susceptibility_to | 0.59341893 |
| 96 | MP0003279_aneurysm | 0.57629996 |
| 97 | MP0005390_skeleton_phenotype | 0.56929714 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.55604036 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.55445689 |
| 100 | MP0004484_altered_response_of | 0.54606195 |
| 101 | MP0000371_diluted_coat_color | 0.54416497 |
| 102 | MP0001663_abnormal_digestive_system | 0.54037951 |
| 103 | MP0002163_abnormal_gland_morphology | 0.53947767 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.53222195 |
| 105 | MP0008004_abnormal_stomach_pH | 0.53066171 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.51447952 |
| 107 | MP0005023_abnormal_wound_healing | 0.51032692 |
| 108 | MP0003075_altered_response_to | 0.50608542 |
| 109 | MP0003795_abnormal_bone_structure | 0.49435553 |
| 110 | MP0001191_abnormal_skin_condition | 0.48478849 |
| 111 | MP0003091_abnormal_cell_migration | 0.47510496 |
| 112 | MP0010094_abnormal_chromosome_stability | 0.44135935 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.43014889 |
| 114 | MP0003077_abnormal_cell_cycle | 0.42647601 |
| 115 | MP0008058_abnormal_DNA_repair | 0.42299791 |
| 116 | MP0000313_abnormal_cell_death | 0.41437450 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.41041222 |
| 118 | MP0003943_abnormal_hepatobiliary_system | 0.40254442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.49685467 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.28142416 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.10646331 |
| 4 | Myositis (HP:0100614) | 4.86555243 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.84232204 |
| 6 | Chronic otitis media (HP:0000389) | 4.82831242 |
| 7 | T lymphocytopenia (HP:0005403) | 4.78521426 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.70211056 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.58498776 |
| 10 | Recurrent viral infections (HP:0004429) | 4.54564036 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.44406069 |
| 12 | IgM deficiency (HP:0002850) | 4.13453081 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 3.98300706 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.98300706 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.96244824 |
| 16 | Optic neuritis (HP:0100653) | 3.96244824 |
| 17 | Abnormality of T cells (HP:0002843) | 3.93679908 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.91318477 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.89865932 |
| 20 | Vasculitis (HP:0002633) | 3.89153207 |
| 21 | Orchitis (HP:0100796) | 3.84498856 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.83220546 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.79029201 |
| 24 | Meningitis (HP:0001287) | 3.71553289 |
| 25 | Increased IgM level (HP:0003496) | 3.67247101 |
| 26 | IgG deficiency (HP:0004315) | 3.65637335 |
| 27 | Recurrent skin infections (HP:0001581) | 3.63416952 |
| 28 | Nasal polyposis (HP:0100582) | 3.62063055 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.55863671 |
| 30 | Stomatitis (HP:0010280) | 3.44200478 |
| 31 | Pustule (HP:0200039) | 3.40980825 |
| 32 | Lymphopenia (HP:0001888) | 3.34048468 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 3.33447668 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 3.32281727 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.31969644 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 3.28272515 |
| 37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.27872614 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25626896 |
| 39 | Obstructive lung disease (HP:0006536) | 3.25626896 |
| 40 | Abnormality of macrophages (HP:0004311) | 3.23217628 |
| 41 | Combined immunodeficiency (HP:0005387) | 3.22217554 |
| 42 | Thyroiditis (HP:0100646) | 3.22146411 |
| 43 | Inflammation of the large intestine (HP:0002037) | 3.20920076 |
| 44 | Eosinophilia (HP:0001880) | 3.17590751 |
| 45 | Abnormality of eosinophils (HP:0001879) | 3.11536850 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 3.10489383 |
| 47 | Recurrent sinusitis (HP:0011108) | 3.10220767 |
| 48 | Leukocytosis (HP:0001974) | 3.09852997 |
| 49 | Colitis (HP:0002583) | 3.07960560 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 3.07100196 |
| 51 | Pulmonary infiltrates (HP:0002113) | 3.06907273 |
| 52 | Gastrointestinal stroma tumor (HP:0100723) | 3.06129714 |
| 53 | Chronic sinusitis (HP:0011109) | 3.03520330 |
| 54 | Cellulitis (HP:0100658) | 3.03041732 |
| 55 | Abnormality of the fingertips (HP:0001211) | 3.00948482 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.98028988 |
| 57 | Encephalitis (HP:0002383) | 2.97544263 |
| 58 | Chronic diarrhea (HP:0002028) | 2.96559985 |
| 59 | Thrombocytosis (HP:0001894) | 2.94249459 |
| 60 | IgA deficiency (HP:0002720) | 2.93586887 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.87175348 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.86651418 |
| 63 | Granulocytopenia (HP:0001913) | 2.86214122 |
| 64 | Hemoptysis (HP:0002105) | 2.85629343 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.85114592 |
| 66 | B lymphocytopenia (HP:0010976) | 2.85114592 |
| 67 | Gingivitis (HP:0000230) | 2.74948619 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.68334047 |
| 69 | Arterial thrombosis (HP:0004420) | 2.67853583 |
| 70 | Keratoconjunctivitis (HP:0001096) | 2.67182979 |
| 71 | Periodontitis (HP:0000704) | 2.62145816 |
| 72 | Bronchitis (HP:0012387) | 2.55452224 |
| 73 | Petechiae (HP:0000967) | 2.54241670 |
| 74 | Recurrent pneumonia (HP:0006532) | 2.50208849 |
| 75 | Emphysema (HP:0002097) | 2.49324740 |
| 76 | Gangrene (HP:0100758) | 2.48408749 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.47018853 |
| 78 | Joint swelling (HP:0001386) | 2.46935438 |
| 79 | Increased IgE level (HP:0003212) | 2.46509886 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.45473671 |
| 81 | Lymphoma (HP:0002665) | 2.44944045 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.41666006 |
| 83 | Hematochezia (HP:0002573) | 2.40916091 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.39728905 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37583132 |
| 86 | Anorexia (HP:0002039) | 2.36133248 |
| 87 | Chest pain (HP:0100749) | 2.35339802 |
| 88 | Epistaxis (HP:0000421) | 2.35161966 |
| 89 | Gingival bleeding (HP:0000225) | 2.30814410 |
| 90 | Peritonitis (HP:0002586) | 2.30771651 |
| 91 | Osteomyelitis (HP:0002754) | 2.27277544 |
| 92 | Verrucae (HP:0200043) | 2.24024631 |
| 93 | Papilloma (HP:0012740) | 2.24024631 |
| 94 | Skin ulcer (HP:0200042) | 2.20107797 |
| 95 | Vacuolated lymphocytes (HP:0001922) | 2.13635172 |
| 96 | Abnormality of the pericardium (HP:0001697) | 2.10125531 |
| 97 | Keratitis (HP:0000491) | 2.07914066 |
| 98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06939953 |
| 99 | Sepsis (HP:0100806) | 2.04660370 |
| 100 | Stomach cancer (HP:0012126) | 2.03211597 |
| 101 | Spondylolisthesis (HP:0003302) | 2.02958665 |
| 102 | Restrictive lung disease (HP:0002091) | 1.99933862 |
| 103 | Arthralgia (HP:0002829) | 1.99560108 |
| 104 | Hypoplasia of the thymus (HP:0000778) | 1.99200504 |
| 105 | Urticaria (HP:0001025) | 1.98995453 |
| 106 | Abnormality of the pleura (HP:0002103) | 1.98377095 |
| 107 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97851330 |
| 108 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97851330 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97851330 |
| 110 | Polyneuropathy (HP:0001271) | 1.96059597 |
| 111 | Hypochromic anemia (HP:0001931) | 1.95598670 |
| 112 | Prostate neoplasm (HP:0100787) | 1.95250746 |
| 113 | Glomerulopathy (HP:0100820) | 1.95195479 |
| 114 | Pulmonary embolism (HP:0002204) | 1.94090535 |
| 115 | Cheilitis (HP:0100825) | 1.93664358 |
| 116 | Acute hepatic failure (HP:0006554) | 1.88643634 |
| 117 | Skin rash (HP:0000988) | 1.85971838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.11689795 |
| 2 | TXK | 4.44272811 |
| 3 | MAP3K14 | 3.35012911 |
| 4 | TYK2 | 3.31254316 |
| 5 | JAK3 | 3.13949508 |
| 6 | IKBKE | 2.98019338 |
| 7 | BLK | 2.86089059 |
| 8 | IRAK4 | 2.67538833 |
| 9 | FRK | 2.58926958 |
| 10 | TBK1 | 2.57902526 |
| 11 | ZAP70 | 2.48694774 |
| 12 | KIT | 2.44274393 |
| 13 | JAK1 | 2.39873840 |
| 14 | STK10 | 2.29298807 |
| 15 | ITK | 2.19096868 |
| 16 | FGFR4 | 2.15022061 |
| 17 | SYK | 1.96159396 |
| 18 | BTK | 1.96087857 |
| 19 | MAP3K13 | 1.92761768 |
| 20 | TEC | 1.91502515 |
| 21 | CSK | 1.90058830 |
| 22 | IKBKB | 1.77974989 |
| 23 | LCK | 1.72631910 |
| 24 | GRK6 | 1.72522973 |
| 25 | RIPK4 | 1.63062306 |
| 26 | IRAK3 | 1.56005111 |
| 27 | FGFR3 | 1.55426957 |
| 28 | CSF1R | 1.53120313 |
| 29 | HCK | 1.52154908 |
| 30 | PIK3CG | 1.49761799 |
| 31 | NLK | 1.44119087 |
| 32 | MST4 | 1.38485231 |
| 33 | CLK1 | 1.28554414 |
| 34 | LYN | 1.26408270 |
| 35 | KDR | 1.23599871 |
| 36 | TGFBR2 | 1.21827627 |
| 37 | FES | 1.21125489 |
| 38 | ERN1 | 1.15597250 |
| 39 | PIM1 | 1.13209894 |
| 40 | CHUK | 1.08861980 |
| 41 | TAOK3 | 1.07223301 |
| 42 | LRRK2 | 1.06967828 |
| 43 | EPHB1 | 1.06329532 |
| 44 | MARK3 | 1.05973987 |
| 45 | CAMKK2 | 1.05460158 |
| 46 | PRKCQ | 1.04881957 |
| 47 | PRPF4B | 1.03637906 |
| 48 | SIK3 | 1.00195370 |
| 49 | ACVR1B | 0.99634151 |
| 50 | MAP3K3 | 0.91390986 |
| 51 | SIK2 | 0.85930666 |
| 52 | RPS6KA4 | 0.85917725 |
| 53 | MAP3K10 | 0.84292991 |
| 54 | PTK2B | 0.83972029 |
| 55 | FLT3 | 0.83353651 |
| 56 | PIM2 | 0.83150577 |
| 57 | JAK2 | 0.80663942 |
| 58 | STK4 | 0.78587701 |
| 59 | NME2 | 0.78503733 |
| 60 | TNK2 | 0.73599429 |
| 61 | EPHA3 | 0.72234195 |
| 62 | CDC42BPA | 0.70983162 |
| 63 | TRPM7 | 0.67320814 |
| 64 | NEK9 | 0.66201663 |
| 65 | MAP2K3 | 0.61931146 |
| 66 | MAP3K1 | 0.60839155 |
| 67 | ADRBK2 | 0.60287639 |
| 68 | PRKCH | 0.58837361 |
| 69 | NUAK1 | 0.54099845 |
| 70 | MAP3K11 | 0.53202770 |
| 71 | SGK2 | 0.52703531 |
| 72 | MELK | 0.51833767 |
| 73 | IRAK1 | 0.51732875 |
| 74 | ADRBK1 | 0.51302363 |
| 75 | TLK1 | 0.51203405 |
| 76 | EIF2AK2 | 0.50974345 |
| 77 | GRK5 | 0.48482988 |
| 78 | MAP3K7 | 0.48291689 |
| 79 | PRKD2 | 0.47306494 |
| 80 | PRKCD | 0.45477533 |
| 81 | MAP3K12 | 0.44354581 |
| 82 | CDK4 | 0.43623602 |
| 83 | TAOK2 | 0.43447699 |
| 84 | WNK1 | 0.43095580 |
| 85 | SGK3 | 0.40902152 |
| 86 | ABL1 | 0.40651497 |
| 87 | MAPK11 | 0.40092280 |
| 88 | RPS6KA6 | 0.39813621 |
| 89 | MATK | 0.39590756 |
| 90 | MAP3K6 | 0.39582552 |
| 91 | CDK12 | 0.39576938 |
| 92 | TTN | 0.38203471 |
| 93 | TGFBR1 | 0.37661762 |
| 94 | STK38 | 0.37014936 |
| 95 | BMPR2 | 0.36680258 |
| 96 | FYN | 0.36196732 |
| 97 | STK24 | 0.35885643 |
| 98 | MAP3K2 | 0.35141196 |
| 99 | FGR | 0.35061062 |
| 100 | MAPK4 | 0.33256089 |
| 101 | MAP2K6 | 0.33180058 |
| 102 | TESK2 | 0.33004500 |
| 103 | HIPK2 | 0.32359697 |
| 104 | RPS6KA5 | 0.31863265 |
| 105 | YES1 | 0.31666462 |
| 106 | MAPKAPK2 | 0.31189691 |
| 107 | ATR | 0.29855980 |
| 108 | EGFR | 0.29583829 |
| 109 | IGF1R | 0.29582298 |
| 110 | MAP3K5 | 0.29017330 |
| 111 | MARK2 | 0.28854616 |
| 112 | PDK1 | 0.28061898 |
| 113 | CAMKK1 | 0.27919653 |
| 114 | GRK1 | 0.27456636 |
| 115 | MAPK7 | 0.27320021 |
| 116 | INSR | 0.27008593 |
| 117 | EEF2K | 0.25436358 |
| 118 | PRKAA2 | 0.25428797 |
| 119 | RPS6KC1 | 0.25397146 |
| 120 | RPS6KL1 | 0.25397146 |
| 121 | PDPK1 | 0.24841600 |
| 122 | CDK9 | 0.24220071 |
| 123 | PDGFRB | 0.24126051 |
| 124 | MAPK3 | 0.23673770 |
| 125 | CDK6 | 0.20958165 |
| 126 | TIE1 | 0.20629496 |
| 127 | MAPK12 | 0.19947464 |
| 128 | GRK7 | 0.19546222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.42131927 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.17282691 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.02587017 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.81239364 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.80336631 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.77943036 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72537189 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.57694286 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55290746 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.51343562 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39891313 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.29660348 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.28433264 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.24308445 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.23885731 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12435802 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12391075 |
| 18 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.88221424 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82787563 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81874700 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.75631102 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71874116 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68185263 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64546541 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.58785270 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50376857 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48059453 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.47620389 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.45220313 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.42288098 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39548010 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36242153 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36137544 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.35935373 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35244791 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.31587234 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26574153 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25819615 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.24914216 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.23782407 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.11136875 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09380906 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07888396 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.04004815 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01502754 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99085749 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.88722016 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83852046 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82355480 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81209762 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78551382 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77172182 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76250957 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75888355 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73879441 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72184844 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68907523 |
| 58 | Base excision repair_Homo sapiens_hsa03410 | 0.67964537 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67834830 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65416248 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64765742 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62078918 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.58879399 |
| 64 | DNA replication_Homo sapiens_hsa03030 | 0.58784718 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57099535 |
| 66 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56796323 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55978218 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55923565 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53828699 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49957015 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49299936 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48476538 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48006447 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47489017 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45187823 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.45126014 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44892217 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.43711046 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42865023 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41525931 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38962247 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38454255 |
| 83 | Mismatch repair_Homo sapiens_hsa03430 | 0.38264625 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38245586 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37229034 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36730260 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.34654107 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31329937 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29812298 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28693612 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28561325 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27209886 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26703891 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26177324 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25814985 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25414489 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.24110442 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23725517 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.23693993 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.23656224 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23292449 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22975435 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22956930 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.21665275 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21608553 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21146656 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21142029 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.20719710 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20470156 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20397845 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20211747 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18884541 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18754568 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15620606 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15066345 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14558277 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.14106263 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.13930901 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.13869370 |

